PRIMARY STUDY

Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study

Key Findings:  Following the cannabis treatment, behavioral outbreaks were much improved or very much improved in 61% of patients. This preliminary study supports feasibility of CBD-based cannabis trials in children with ASD.

Type of Study:  Human Trial

Study Sample Size:  60

Study Result:  Positive

Study Location(s):  Israel

Year of Pub:  2019


Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC)

Phytocannabinoid Source:  Unspecified

Chemotype:  Chemotype III